Initial Diagnosis:\tFIGO stage 3C HGS Ovarian cancer with omental disease tethered to the sigmoid colon  gBRCA,   sBRCA1&2 - NO MUTATION. No HR deficiency. GIS=7.  No WGS  TSO500 requested 30/6/2023  HLA-A2 requested 4/7/23  \nChemotherapy:\tNeoadjuvant carbo taxol x 3 then consider IDS  Cycle 1 as a PP to start treatment more quickly  \nOther:\tRight internal iliac thrombus - on tinzaparin then rivaroxaban then apixaban for 6 months then reduced to prophylactic 2.5mg bd long term  \nSurgery\tIDS with colorectal support.  TAH BSO peritonectomy, rectosigmoid colectomy with end to end anastomosis and loop ileostomy.  Residual disease <1cm (ascending and transverse colon serosa 2-3mm)  \nOther:\tCA-125=135 pre-treatment  \nChemotherapy:\tCarbo-taxol x 3   ca125 = 6, CT: no definitive disease seen  \nBiological Therapy:\tNiraparib   \nRelapse:\tRelapse with peritoneal nodules and asymmetry of the breast tissue (breast team review of imaging - breast clinic not needed)  Ca125 4  \nHormone Therapy:\tletrozole  \nProgression:\tSlow low volume PD on letrozole   to consider FONTANA study (FR-alpha)  \nSystemic Treatment:\tFONTANA TRIAL monotherapy AZD5335 IV Q3W 2/10/2024 - 6/10/2025 (Planned)  \nOther:\tCT scan showed maintained partial response. To continue on trial.